BridgeBio Pharma, Inc. (BBIO)
68.41
+0.50
(+0.74%)
USD |
NASDAQ |
Feb 24, 16:00
70.14
+1.73
(+2.53%)
After-Hours: 20:00
BridgeBio Pharma Price : 68.41 for Feb. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Insmed, Inc. | 158.65 |
| Mirum Pharmaceuticals, Inc. | 107.56 |
| Cogent Biosciences, Inc. | 39.16 |
| Alnylam Pharmaceuticals, Inc. | 332.59 |
| Sarepta Therapeutics, Inc. | 18.84 |
Price Related Metrics
| PS Ratio | 36.83 |
| PEG Ratio | -0.2220 |
| Earnings Yield | -6.12% |
| Market Cap | 13.11B |
| PEGY Ratio | -0.2220 |